FDA UDI
In Commercial Distribution
🇺🇸 United States
OptiScanner 5000 Glucose Monitoring System
DI: 00850003892504
·
Model: 5000
·
OPTISCAN BIOMEDICAL CORPORATION
Product Codes
2
GMDN Terms
1
Identifiers
1
Pkg Device Count
1
Basic Information
- Brand Name
- OptiScanner 5000 Glucose Monitoring System
- Primary DI
- 00850003892504
- Version / Model
- 5000
- Catalog Number
- OPTI-5
- Company Name
- OPTISCAN BIOMEDICAL CORPORATION
- Labeler DUNS
- 939218384
- Distribution Status
- In Commercial Distribution
- Device Count in Pkg
- 1
- Record Status
- Published
- Publish Date
- 2018-12-31
- Public Version
- 2
- Public Version Date
- 2020-09-09
- Public Version Status
- Update
- Public Device Record Key
- 85903bd2-c994-4db1-8f6c-a2d72f7da1d0
Device Description
Automated, in-line, bedside, glucose monitoring system
Device Characteristics
- Single Use
- No
- Prescription Use (Rx)
- Yes
- Over the Counter (OTC)
- No
- Kit
- No
- Combination Product
- No
- HCT/P
- No
- Contains NRL
- No
- Not Made with NRL
- No
- MRI Safety
- MR Unsafe
- Direct Marking Exempt
- No
- PM Exempt
- No
- Has Serial Number
- Yes
- Has Lot/Batch Number
- No
- Has Manufacturing Date
- Yes
- Has Expiration Date
- No
- Has Donation ID
- No
Sterilization
- Is Sterile
- No
- Sterilization Prior Use
- No
Product Codes
| Code | Name | Medical Specialty | Regulation # | Device Class |
|---|---|---|---|---|
| PYV | Hospital Continuous Glucose Monitoring System | Clinical Chemistry | 862.1345 | 2 |
| LZF | Pump, Infusion, Analytical Sampling | General Hospital | 880.5725 | 2 |
GMDN Terms
| Code | Name | Definition | Implantable | Status |
|---|---|---|---|---|
| 58436 | Point-of-care blood glucose monitoring system | An assembly of devices intended to be operated by a healthcare professional to continually measure patient blood glucose at the point-of-care in a healthcare facility. It is continuously connected to the patient during use and typically consists of a line-powered control unit, with user interface and rechargeable battery, containing a spectrometer to quantitatively measure glucose concentration in received plasma samples; a sterile, single-use cartridge connected to the patient via a venous catheter designed to withdraw a blood sample at intervals, convert it to plasma, and transport it to the control unit for analysis; a heparin syringe; and a sterile cap to protect the patient connector. | No | Active |
Identifiers
| Type | ID | Issuing Agency | Package Type | Qty per Pkg | Pkg Status | Pkg Discontinue Date |
|---|---|---|---|---|---|---|
| Primary | 00850003892504 | GS1 |
Customer Contacts
- Phone
- 510.962.6207
- [email protected]
- Phone
- 510.342.5818
- [email protected]
Premarket Submissions
| Submission Number | Supplement Number |
|---|---|
| K162042 | 000 |